Drug-induced hyperkalemia: old culprits and new offenders

This publication has 62 references indexed in Scilit:

• Rapid Life-Threatening Hyperkalemia After Addition of Amiloride HC1/Hydrochlorothiazide to Angiotensin-Converting Enzyme Inhibitor Therapy
  Annals of Emergency Medicine, 1997
• Biochemical Effects of Losartan, a Nonpeptide Angiotensin II Receptor Antagonist, on the Renin-Angiotensin-Aldosterone System in Hypertensive Patients
  Hypertension, 1995
• Renal Effects of Prostaglandins and Clinical Adverse Effects of Nonsteroidal Anti-Inflammatory Agents
  Medicine, 1984
• The effect of adrenergic blockade on potassium concentrations in different conditions
  Acta Medica Scandinavica, 1983
• Drug attributed alterations in potassium handling in congestive cardiac failure
  European Journal of Clinical Pharmacology, 1982
• Hyperkalemic Distal Renal Tubular Acidosis Associated with Obstructive Uropathy
  New England Journal of Medicine, 1981
• Adrenergic Modulation of Extrarenal Potassium Disposal
  New England Journal of Medicine, 1980
• Interruption of the renin-angiotensin system in hypertensive patients by captopril induces sustained reduction in aldosterone secretion, potassium retention and natruiresis.
  Hypertension, 1979
• Potassium Load in CPD‐Preserved Whole Blood and Two Types of Packed Red Blood Cells
  Transfusion, 1975
• Suicidal and Accidental Digoxin Ingestion
  Circulation, 1971